Risk of suicidal ideation with weight-loss drugs being investigated by European regulators
European Medicines Agency reviewing semaglutide and liraglutide after reports of links to suicidal thoughts and self-harm.
The European Medicines Agency is looking into concerns that weight-loss drugs like semaglutide and liraglutide may be linked to suicidal ideation and potential self-harm.
Three case reports from Iceland spurred the agency’s safety committee to conduct a medication review, CNN reported Monday.
